Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease MACHINE LEARNING MODEL USING ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...
News Medical on MSN2d
Alzheimer’s Discovery Opens the Way to Complimentary Drug TreatmentsA complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau.
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...
Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback